Vaginal Elasticity Assessment Before and After Brachytherapy/Pelvic Radiation

Condition:   Radiation Injuries Intervention:   Diagnostic Test: Vaginal Tactile Imaging Sponsor:   Rambam Health Care Campus Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials

Related Links:

AbstractPurpose of ReviewFollowing partial mastectomy, whole-breast irradiation (WBI), delivered over 3 to 6  weeks, has been the standard adjuvant radiation approach for early-stage breast cancer. A growing body of literature over the past decade has suggested that irradiation of the partial breast, including the tumor bed plus a margin, may be a suitable alternative for appropriately selected patients. The use of partial breast irradiation (PBI) has been studied in multiple prospective randomized trials, now with up to 10 years of follow-up, establishing similar safety and efficacy compared with WBI. Advantages...
Source: Current Breast Cancer Reports - Category: Cancer & Oncology Source Type: research
We report our institution's high-volume experience and the most mature data to date on outcomes with 131Cs prostate BT.
Source: Brachytherapy - Category: Cancer & Oncology Authors: Source Type: research
Conclusion: VMAT combined with IC/IS BT can result in satisfactory curative outcomes and low incidences of late radiation enterocolitis and cystitis in CC treatment.
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research
The U.S. Nuclear Regulatory Commission (NRC) is proposing several updates in...Read more on AuntMinnie.comRelated Reading: NRC offers options for radiopharmaceutical training NRC taking feedback on radiopharma user rules Can radiation therapy and cremation safely coexist? Ontario ban on cremation after brachytherapy draws scrutiny NRC publishes rules on medical byproducts
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news
High ‐dose‐rate interstitial brachytherapy (HDR‐ISBT) achieved excellent local control of the bulky sebaceous carcinoma of the eyelid. However, we must pay attention to dose of eyelid and cornea about late toxicity of HDR‐ISBT. AbstractHigh ‐dose‐rate interstitial brachytherapy (HDR‐ISBT) achieved excellent local control of the bulky sebaceous carcinoma of the eyelid. However, we must pay attention to dose of eyelid and cornea about late toxicity of HDR‐ISBT.
Source: Clinical Case Reports - Category: General Medicine Authors: Tags: CASE REPORT Source Type: research
This article aims at interpreting the adverse reactions and complications after the implantation of radioactive seeds.
Source: Journal of Cancer Research and Therapeutics - Category: Cancer & Oncology Authors: Source Type: research
Conclusion: For immobilized malignant tumors, 3D-printed template can be used reproducibly. The dose parameters in preplan can be achieved easily and satisfactorily by 3D-printed template guided brachytherapy, and it may become an easily reproducible standardized procedure in the future.
Source: Journal of Cancer Research and Therapeutics - Category: Cancer & Oncology Authors: Source Type: research
Conclusions: CT-MRI image fusion is feasible for the design, optimization, and verification of treatment planning. CT-MRI fusion-based brachytherapy may improve dosimetry of brain tumor while sparing the normal structures, potentially impacting disease control, treatment-related toxicity, and long-term survival.
Source: Journal of Cancer Research and Therapeutics - Category: Cancer & Oncology Authors: Source Type: research
Introduction: Definitive chemoradiotherapy (CRT) followed by high-dose-rate (HDR) brachytherapy (BT) is the state-of-the-art treatment for locally advanced (≥ FIGO IIb) cervical cancer but three-year survival rates are stagnating in recent years indicating the need for biomarker development and patient’s stratification. In the present study we aimed to analyse the predictive relevance of Polo-like kinase (PLK) 3 expression and levels of Caspase 8 T273 phosphorylation in patients with advanced cervical squamous cell carcinoma (CSCC) treated with CRT and BT. Methods: In a cohort of 74 patients with FIGO Stage Ib...
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research
Hepatocellular carcinoma (HCC) is the most common type of malignant primary liver tumour, accounting for 80 –90% of all liver cancers. [1] In the USA, for example, 30,640 new liver and intrahepatic bile duct cancers are estimated to have occurred in 2013, with 21,670 associated deaths. [2–3]
Source: Journal of Hepatology - Category: Gastroenterology Authors: Source Type: research
More News: Brachytherapy | Research